View in EDS PDF Full Text

Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design.

Saved in:
Bibliographic Details
Title: Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design.
Authors: Rudraraju RS; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, United States., Daher SS; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States., Gallardo-Macias R; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States., Wang X; Department of Immunology and Infectious Diseases, Harvard University T.H. Chan School of Public Health, Boston, MA, United States., Neiditch MB; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, United States., Freundlich JS; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States.; Department of Medicine, Center for Emerging and Re-emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Sep 15; Vol. 12, pp. 1008213. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36189349
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rudraraju+RS%22">Rudraraju RS</searchLink>; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Daher+SS%22">Daher SS</searchLink>; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Gallardo-Macias+R%22">Gallardo-Macias R</searchLink>; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Immunology and Infectious Diseases, Harvard University T.H. Chan School of Public Health, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Neiditch+MB%22">Neiditch MB</searchLink>; Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Freundlich+JS%22">Freundlich JS</searchLink>; Department of Pharmacology, Physiology, and Neuroscience, New Jersey Medical School, Rutgers University, Newark, NJ, United States.; Department of Medicine, Center for Emerging and Re-emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101585359%22">Frontiers in cellular and infection microbiology</searchLink> [Front Cell Infect Microbiol] 2022 Sep 15; Vol. 12, pp. 1008213. <i>Date of Electronic Publication: </i>2022 Sep 15 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+SA%22">Frontiers Media SA </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101585359 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2235-2988 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222352988%22">22352988 </searchLink><i>NLM ISO Abbreviation: </i>Front Cell Infect Microbiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36189349
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcimb.2022.1008213
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1008213
    Titles:
      – TitleFull: Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rudraraju RS
      – PersonEntity:
          Name:
            NameFull: Daher SS
      – PersonEntity:
          Name:
            NameFull: Gallardo-Macias R
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Neiditch MB
      – PersonEntity:
          Name:
            NameFull: Freundlich JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 09
              Text: 2022 Sep 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2235-2988
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in cellular and infection microbiology
              Type: main
ResultId 1